MindMaze Therapeutics Holding S.A.
OTC: RLFTY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Zach Henderson
- Employees
- 10
- Headquarters
- Geneva, Switzerland
- IPO year
- 2025
- Market cap
- $5.3M
- Website
- http://www.mindmazetherapeutics.com
Loading RLFTY…
Loading profile data…Frequently asked questions about RLFTY
What does MindMaze Therapeutics Holding S.A. (RLFTY) do?
MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, wh...
Where does RLFTY trade?
MindMaze Therapeutics Holding S.A. (RLFTY) trades on the Other OTC.
What sector is RLFTY in?
MindMaze Therapeutics Holding S.A. (RLFTY) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of MindMaze Therapeutics Holding S.A.?
Zach Henderson is the chief executive officer of MindMaze Therapeutics Holding S.A. (RLFTY).
Where is MindMaze Therapeutics Holding S.A. headquartered?
MindMaze Therapeutics Holding S.A. is headquartered in Switzerland.
Does RLFTY pay a dividend?
MindMaze Therapeutics Holding S.A. (RLFTY) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RLFTY go public?
MindMaze Therapeutics Holding S.A. (RLFTY) completed its initial public offering in 2025.